News Daily News PREDIMED Analysis May Rekindle Hope for Wine’s Heart Benefits Michael O'Riordan December 18, 2024
News Daily News PREVENT Tool Accurately Predicts HF Risk, With ‘Strong’ ASCVD Overlap Yael L. Maxwell December 17, 2024
News Daily News FINEARTS-HF Analysis Supports Finerenone’s Value in HFpEF With Obesity L.A. McKeown December 13, 2024
News Daily News Teens Who Smoke Face Risk of Cardiac Damage by Their Mid-20s Caitlin E. Cox December 12, 2024
News Daily News Female-Specific Factors Don’t Enhance Common Risk Calculators Caitlin E. Cox December 10, 2024
News Daily News Could Pricey GLP-1 Drugs Cut Healthcare Costs? The Math Isn’t Simple L.A. McKeown December 09, 2024
News Daily News Tirzepatide Bests Semaglutide for Weight Loss: SURMOUNT-5 Top-line Results Michael O'Riordan December 04, 2024
News Daily News Increased CVD Risk Seen Up to 30 Years Before Type 2 Diabetes Diagnosis Todd Neale November 28, 2024
News Daily News CMS Proposal Would Expand Medicare, Medicaid Coverage for GLP-1 Drugs Todd Neale November 27, 2024
News Daily News Rural Counties Bore Brunt of Worsening CV Mortality During Pandemic Yael L. Maxwell November 15, 2024
News Daily News ChatGPT Again Shows Potential for Guiding Revascularization Decisions Yael L. Maxwell November 14, 2024
News Daily News Many Patients Quit Taking GLP-1 Drugs: Understanding Why Is Key Todd Neale November 13, 2024
News Daily News Hypertensive Disorders of Pregnancy Lead to Earlier, More Severe CAD Caitlin E. Cox November 12, 2024
News Daily News Rosuvastatin Bests Atorvastatin for Reducing CVD Risk: Registry Data Michael O'Riordan November 07, 2024
News Daily News Machismo in Youth Linked to Fewer CVD Diagnoses, Less Treatment in Adulthood Caitlin E. Cox November 06, 2024
News Daily News SOUL: Oral Semaglutide Cuts CV Events in Diabetic Patients L.A. McKeown October 23, 2024